Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis
Public ClinicalTrials.gov record NCT05152173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis
Study identification
- NCT ID
- NCT05152173
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Enrollment
- 176 participants
Conditions and interventions
Conditions
Interventions
- EN3835 Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 28, 2021
- Primary completion
- Jan 9, 2023
- Completion
- Jan 9, 2023
- Last update posted
- Mar 26, 2026
2021 – 2023
United States locations
- U.S. sites
- 43
- U.S. states
- 14
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endo Clinical Trial Site #29 | Mesa | Arizona | 85206 | — |
| Endo Clinical Trial Site #42 | Tucson | Arizona | 85712 | — |
| Endo Clinical Trial Site #15 | Bakersfield | California | 93311 | — |
| Endo Clinical Trial Site #41 | Encinitas | California | 92024 | — |
| Endo Clinical Trial Site #9 | Fresno | California | 93710 | — |
| Endo Clinical Trial Site #27 | La Mesa | California | 91942 | — |
| Endo Clinical Trial Site #30 | Los Angeles | California | 90010 | — |
| Endo Clinical Trial Site #12 | Tarzana | California | 91356 | — |
| Endo Clinical Trial Site #36 | Torrance | California | 90502 | — |
| Endo Clinical Trial Site #22 | Vista | California | 92083 | — |
| Endo Clinical Trial Site #13 | Whittier | California | 90603 | — |
| Endo Clinical Trial Site #16 | Atlantis | Florida | 33462 | — |
| Endo Clinical Trial Site #43 | Jacksonville | Florida | 32209 | — |
| Endo Clinical Trial Site #40 | Miami | Florida | 33176 | — |
| Endo Clinical Trial Site #10 | Pinellas Park | Florida | 33782 | — |
| Endo Clinical Trial Site #3 | South Miami | Florida | 33143 | — |
| Endo Clinical Trial Site #14 | Sweetwater | Florida | 33172 | — |
| Endo Clinical Trial Site #38 | Lawrenceville | Georgia | 30043 | — |
| Endo Clinical Trial Site #31 | Meridian | Idaho | 83642 | — |
| Endo Clinical Trial Site #32 | Decatur | Illinois | 62521 | — |
| Endo Clinical Trial Site #19 | O'Fallon | Illinois | 62269 | — |
| Endo Clinical Trial Site #33 | Springfield | Illinois | 62704 | — |
| Endo Clinical Trial Site #23 | Pasadena | Maryland | 21122 | — |
| Endo Clinical Trial Site #28 | Jefferson City | Missouri | 65109 | — |
| Endo Clinical Trial Site #20 | Las Vegas | Nevada | 89119 | — |
| Endo Clinical Trial Site #34 | Oklahoma City | Oklahoma | 73109 | — |
| Endo Clinical Trial Site #4 | York | Pennsylvania | 17402 | — |
| Endo Clinical Trial Site #35 | Arlington | Texas | 76015 | — |
| Endo Clinical Trial Site #5 | Bedford | Texas | 76021 | — |
| Endo Clinical Trial Site #24 | Cedar Park | Texas | 78613 | — |
| Endo Clinical Trial Site #17 | Dallas | Texas | 75208 | — |
| Endo Clinical Trial Site #2 | Dallas | Texas | 75251 | — |
| Endo Clinical Trial Site #7 | Fort Worth | Texas | 76104 | — |
| Endo Clinical Trial Site #39 | Georgetown | Texas | 78628 | — |
| Endo Clinical Trial Site #25 | Houston | Texas | 77027 | — |
| Endo Clinical Trial Site #8 | Houston | Texas | 77095 | — |
| Endo Clinical Trial Site #1 | McAllen | Texas | 78501 | — |
| Endo Clinical Trial Site #21 | San Antonio | Texas | 78211 | — |
| Endo Clinical Trial Site #6 | San Antonio | Texas | 78229 | — |
| Endo Clinical Trial Site #18 | Salt Lake City | Utah | 84107 | — |
| Endo Clinical Trial Site #26 | Lynchburg | Virginia | 24501 | — |
| Endo Clinical Trial Site #37 | Midlothian | Virginia | 23114 | — |
| Endo Clinical Trial Site #11 | Suffolk | Virginia | 23434 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05152173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05152173 live on ClinicalTrials.gov.